Lancet 2 , 603605 (1979)
Saghazadeh, A., Mahmoudi, M., Dehghani Ashkezari, A., Oliaie Rezaie, N
The FDA has received hundreds of adverse event reports associated with compounded GLP-1 medications, often involving dosing errors, improper formulations, or counterfeit products
However, of these, only three in the L-Carnitine-combination, one in the L-Carnitine group, and three in the placebo group were classified as possibly related to the study products
"The webpage referred to a clinical study purportedly finding that 'only 5 per cent of the sunscreens that were tested held up to safety standards' and 'another 40 per cent were said to contribute to developing skin cancer'," documents stated